For experts

How we can help?​

MAYA (smart Mirrors to support healthier lives of Adolescents and Young Adults after cancer) is a four-year project that aims to empower AYA cancer survivors to manage their cardiovascular health and lifestyle with the support of innovative digital tools specifically designed to address cardiotoxic-related late effects of cancer treatment, from the convenience of their homes.

The project’s main objective is to reduce the risk of major cardiac events in AYA cancer survivors by 30-40% by addressing modifiable risk factors such as hypertension, diabetes and obesity, ultimately improving both cardiovascular outcomes and quality of life

Reduce major cardiac events by 30–40%

Target populations and clinical context

Late-onset CV toxicity occurs ≥1 year post-treatment…​

Adolescents and Young Adults (AYA) can develop various cancers, often requiring treatments such as chemotherapy, hormone therapy, targeted therapy, immunotherapy, radiation, and surgery.

Common long-term effects of these treatments include:

  • cardiovascular toxicity (up to 22%) 
  • secondary cancers
  • reduced quality of life
  • mental health problems 
  • chronic fatigue 
  • neurocognitive issues
  • fertility and endocrine disorders 

Late-onset cardiovascular toxicity usually occurs ≥1 year after completion of cancer treatment. It may develop progressively over time or suddenly, triggered by stress or other comorbidities

Late-onset cardiovascular toxicity is common in survivors of childhood, adolescent, and young adult (AYA) cancers, particularly those treated with anthracyclines and/or chest radiation

Who is more at risk?

Genetic predisposition​

Chest radiation​

Female sex​

High cumulative anthracycline dose

(≥250–300 mg/m²)​

Hypertension, diabetes, obesity, smoking​

Clinical importance

Late-onset cardiovascular toxicities can be subclinical (no symptoms initially) or clinical (with symptoms) and are a leading cause of non-cancer morbidity.

→ Early intervention and lifelong surveillance are crucial in preventing disease progression

Technological approach

MAYA uses AI-driven digital health technologies for personalised and context-aware interactions can effectively prevent, monitor, and manage cardiovascular late effects in AYA cancer survivors.

How?

MAYA employs a combination of real-time biomarker tracking, including physiological and behavioural information, along with insights gathered from survivors themselves through the iCARE health hub equipped with a smart mirror and an AI-powered conversational agent. The iCARE health hub isdesigned to monitor and manage late-onset cardiovascular health issues and address gaps in care during the transition to post-
treatment stages.

Additionally, the iCARE hubs aim to improve health literacy by offering personalised coaching, helping survivors better understand and navigate their health. Installing these tools in homes across different European countries will enable us to evaluate their effectiveness and the acceptance of these innovative technologies

Methodological approach

Participatory methodology across every phase

Co-research

Young survivor co-researchers in key phases

Living Lab

8 countries co-create/test/validate in practice

Pilot Sites

5 countries; studies + data for policy recommendations

Project partners

16 partners across Europe and United Kingdom

Consortium & partners

partners
0
Countries
0

Improving cardiovascular health and quality of life after cancer

How can you be involved?​

Join us!

Healthcare professionals & providers (oncology / cardiology / GP / nursing…)
Researchers (AI / HCI / behavioural / SSH / psychology / ethics / informatics…)

Or email us at contact@maya-horizon.eu

Resources

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod

Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia in deserunt mollit anim id est sint laborum. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia in deserunt mollit anim id est sint
No data was found
No data was found

Conferences, symposiums, events